China to Strengthen Drug Sample Survey
Posted on: Saturday, 14 January 2006, 09:00 CST
China to strengthen drug sample survey
BEIJING, Jan. 13 (Xinhua) -- China's food and drug authorities will strengthen their check-ups and supervision over the quality of medicines sold in the countryside this year, said an official at a national food and drug supervision and management meeting here Thursday.
Shao Mingli, director of the State Food and Drug Administration (SFDA), said that the supervision will target medicines that have provoked complaints, are promoted by illegal advertising, or are low- quality.
Especial scrutiny will be made into medicines widely used in clinics or sold in large volumes and those to treat cardiovascular and cerebrovascular diseases.
Surveys for supervision purposes will examine pharmaceutical manufacturers, medicine businesses and users that had problems in last year's sample surveys and also some Chinese medicines and imported medicines.
Source: Xinhua News Agency - CEIS
Related Articles
- Woman Accused of Smuggling Drugs in Food
- Marketing Medicine: Drug Companies Take to TV to Sell Their Wares, and Patients Respond
- Quigley Pharma is Issued Three Investigational New Animal Drug (INAD) Numbers By the FDA To Study Its Anti-Viral Compound On Avian Flu
- DR. M.D.; Bad Medicine; Drug Companies Manipulate and Drive Medical Research
- Myanmar Urges Import of Quality Medicines for Safe Consumption
- Drug makers object to U.S. plan for early warnings
- PROFNET WIRE: HEALTH & MEDICINE: Genetically Modified Food
- New Rules Aim to Speed Up Personalized Medicine
- FDA Warns of Terrorist Prescription Drug Tampering
- FDA Warns of Terrorist Drug Tampering
 |
 |
User Comments (0)
RSS Feeds